Shifting to An Open-Source Backbone Within Clinical Trials with Roche and Genentech

On January 11th, 2023, data science leaders at Roche & Genentech will be joining us to present the organization's shift to an open-source backbone within clinical trials. This shift is the culmination of years of preparation and innovation both within the organization and across the entire pharmaceutical industry. 

You can join the presentation on YouTube Live on the day of the event: https://www.youtube.com/watch?v=nqJsLSLd39A

There's no need to register. Just add the event to your calendar.

Presentation Details

Topic: Moving to a fully open-source clinical reporting workflow as the default for clinical trials at Roche

Problem: When pharmaceutical companies wish to get a new drug approved, they must produce hundreds of tables, plots, and listings to provide the evidence for regulators to assess. Traditionally these were produced using a proprietary language with internally developed tools, and the lifecycle of tools could be measured in decades.
 
In 2023 Roche is moving to a new open-source backbone, with packages co-developed with other companies and a new focus on a continually evolving set of tools that are owned and contributed to by the users. 
 
Over 1,000 statisticians and statistical programmers at Roche need to embrace this transition and adapt to a new set of R/Python tools to deploy our new data science focussed workflows. 
 
Solution: Roche approached preparing for the go-live of end-to-end open source trials in a three-pronged strategy: 
 
1) Build a culture that embraces lifelong learning and self-improvement, allowing our data scientists to take on new skills and languages as the industry evolves
2) Build a plan to ensure study teams are closely supported, with a tight feedback loop between tool developers and the users
3) Co-create tools by focusing on collaborations like the pharmaverse to pool our efforts and accelerate the development of tools across pharma companies.